UBS Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Buy
499,371
+153,713
+44% +$563K ﹤0.01% 3903
2025
Q1
$1.49M Buy
345,658
+288,762
+508% +$1.25M ﹤0.01% 3897
2024
Q4
$182K Sell
56,896
-1,943
-3% -$6.22K ﹤0.01% 5307
2024
Q3
$168K Buy
58,839
+11,797
+25% +$33.7K ﹤0.01% 4828
2024
Q2
$132K Sell
47,042
-28,908
-38% -$80.9K ﹤0.01% 4848
2024
Q1
$216K Buy
75,950
+1,613
+2% +$4.58K ﹤0.01% 4667
2023
Q4
$304K Buy
74,337
+26,290
+55% +$108K ﹤0.01% 4325
2023
Q3
$153K Buy
48,047
+46,046
+2,301% +$146K ﹤0.01% 4445
2023
Q2
$6.64K Sell
2,001
-9,133
-82% -$30.3K ﹤0.01% 6271
2023
Q1
$23.7K Buy
11,134
+5,137
+86% +$10.9K ﹤0.01% 5868
2022
Q4
$16.1K Buy
5,997
+5,996
+599,600% +$16.1K ﹤0.01% 6737
2022
Q3
$0 Hold
1
﹤0.01% 9551
2022
Q2
$0 Hold
1
﹤0.01% 9576
2022
Q1
$0 Sell
1
-589
-100% ﹤0.01% 9474
2021
Q4
$5K Sell
590
-179,118
-100% -$1.52M ﹤0.01% 8282
2021
Q3
$2.56M Buy
179,708
+39,403
+28% +$561K ﹤0.01% 2571
2021
Q2
$2.33M Buy
140,305
+137,988
+5,955% +$2.29M ﹤0.01% 2624
2021
Q1
$42K Sell
2,317
-3,205
-58% -$58.1K ﹤0.01% 5718
2020
Q4
$42K Buy
5,522
+4,378
+383% +$33.3K ﹤0.01% 5339
2020
Q3
$4K Sell
1,144
-8,009
-88% -$28K ﹤0.01% 6539
2020
Q2
$35K Buy
9,153
+2,408
+36% +$9.21K ﹤0.01% 5328
2020
Q1
$22K Sell
6,745
-6,815
-50% -$22.2K ﹤0.01% 5535
2019
Q4
$65K Buy
13,560
+3,148
+30% +$15.1K ﹤0.01% 5169
2019
Q3
$68K Buy
10,412
+5,734
+123% +$37.4K ﹤0.01% 5074
2019
Q2
$36K Buy
+4,678
New +$36K ﹤0.01% 5323
2018
Q3
Sell
-100
Closed -$1K 7126
2018
Q2
$1K Hold
100
﹤0.01% 6892
2018
Q1
$1K Buy
+100
New +$1K ﹤0.01% 6750
2017
Q4
Sell
-500
Closed -$5K 6935
2017
Q3
$5K Hold
500
﹤0.01% 6303
2017
Q2
$5K Hold
500
﹤0.01% 6175
2017
Q1
$5K Buy
+500
New +$5K ﹤0.01% 6056